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Ultraviolet (UV) light is the most common cause of skin
cancer in humans and it is very cute problem in our life
style. Several effects of UVB (290–320 nm) are thought to
contribute to skin carcinogenesis. The generation of free
radicals and related oxidants produced by UVB exposure.
The UVB induced release of biologically active NO from
these skin located stroes of NO-donors is biologically rel-
evant and modulates several cellular process, and it
increases cGMP formation that converts GTP in a NO-
dpendent manner. Tabebuia avellanedae (Bignoniaceae)
(TA), which is native in South America from Brazil to
northern Argentina, is well known in traditional folk
medicine used for the treatment of various disease during
five hundred years. The inner bark of this plant produced
in Brazil is distributed in Asia as a herb tea and healthy
purpose. Previously, we reported that extract essense of TA
(TA ess.) and including naphthoquinones type com-
pounds, NFD, inhibited TPA-induced in vitro assay. The
present study purposed to evaluate for in vivo activity,
using natural sourced materials. We have now extended
these investigations to a new tumorigenesis model in
which we initiated the tumors with UVB irradiation and
promoted with 1.7 nmol of TPA in SENCAR mice. Oral
feeding of 00025% of TA ess. two weeks before and after
tumor initiation resulted in a highly significant reduction
in tumor incidence (40%) accompanied by an extension
(>20%) of the tumor latency TA ess. treatment also
decreased the papilloma incidence and multiplicity when
compared with the control and treatment during 20 weeks
of the promotion. These results provide a basis for further
development of TA ess. for human chemoprevention. To
investigate the inhibitory effects of Tabebuia avellanedae
and its effect of cGMP levels in mouse surface skin pro-
tein. cGMP contents was measured and protein expres-
sion was visualized by Western blotting analysis of MAP
pathway. We posturate that these data suggest possible
role of cancer main pathway and cGMP as regulatory
mechanism of potent activity in UVB induced carcinogen-
esis.
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